- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-64304500-Placebo
Total 54404 results
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorGermany, Netherlands
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCRecruitingMyasthenia GravisUnited States, Japan, Netherlands, Poland
-
Janssen Research & Development, LLCBristol-Myers SquibbCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingSystemic Lupus ErythematosusJapan, Taiwan, Spain, United States, Argentina, Ukraine, Germany, Hungary, Poland, Bulgaria, Colombia, South Africa
-
CCTU-CoreJanssen PharmaceuticalsActive, not recruitingInflammation | Depressive Disorder, MajorUnited Kingdom
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Testosterone Greater Than 150 ng/dLUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHistamine Induced ItchUnited Kingdom
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States, Canada
-
Janssen Vaccines & Prevention B.V.Completed
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, Spain, United States, Germany
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeUnited States, Australia, France, Ukraine, Germany, Israel, Poland, Bulgaria, Romania, Russian Federation, Canada, Netherlands, Belgium, Hungary
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCNot yet recruitingLupus NephritisUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2
-
Janssen Research & Development, LLCCompletedPhobic DisordersUnited States, Australia, Canada
-
Janssen Research & Development, LLCActive, not recruitingHepatitis B, ChronicFrance, Belgium, Italy, United Kingdom, Poland, Spain, New Zealand, Taiwan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, United States, Malaysia, Turkey
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCRecruiting
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, United Kingdom, Taiwan, Israel, Spain, Australia, France
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Scientific Affairs, LLCAvailable
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Janssen Research & Development, LLCTerminatedAdvanced CancerUnited States
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States
-
Janssen Research & Development, LLCTerminatedHidradenitis SuppurativaUnited States, Germany, Canada, Japan, Netherlands, Spain, Australia, Poland
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited Kingdom, Finland, United States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedMyelodysplastic Syndromes | Advanced or Refractory LeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1